4//SEC Filing
Bain Linda 4
Accession 0000899243-23-005697
CIK 0001659352other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:32 PM ET
Size
14.4 KB
Accession
0000899243-23-005697
Insider Transaction Report
Form 4
Bain Linda
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-16+7,613→ 15,982 total - Sale
Common Stock
2023-02-17$0.59/sh−2,570$1,522→ 13,412 total - Exercise/Conversion
Restricted Stock Units
2022-08-16−7,613→ 22,837 total→ Common Stock (7,613 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-16−7,613→ 15,224 total→ Common Stock (7,613 underlying) - Exercise/Conversion
Common Stock
2022-08-16+7,613→ 10,733 total - Sale
Common Stock
2022-08-17$2.21/sh−2,364$5,231→ 8,369 total
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On February 16, 2022, the reporting person was granted 30,450 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.
Documents
Issuer
Codiak BioSciences, Inc.
CIK 0001659352
Entity typeother
Related Parties
1- filerCIK 0001578407
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:32 PM ET
- Size
- 14.4 KB